3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
18
Neoplasms, Hormone-Dependent
2
Carcinoma, Lobular
2
Carcinoma, Ductal, Breast
2
Polycystic Ovary Syndrome
1
Hot Flashes
1
Breast Cancer Metastatic
1
Advanced Breast Cancer
1
Interventions
fluzoparib
1
exemestane
1
dalpiciclib
1
Trastuzumab
1
Letrozole
1
Ga(III)-DOTATOC
1
Everolimus
1
Docetaxel
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Breast Cancer Metastatic
×
Aromatase Inhibitors
×
Clear all
NCT02511639
2020-12-03
MAIN-A
Istituto Oncologico Veneto IRCCS
Phase 3
Completed
110 enrolled